Why is TMD.TO stock moving in pre-market trading?

TMD.TO stock moved on heavy volume likely due to low float and speculative buying. There was no confirmed Titan Medical press release at the time of writing. High relative volume (**2.55x**) and a gap from **C$0.05** to **C$1.13** drive volatility.

What price targets does Meyka AI give for TMD.TO stock?

Meyka AI's model shows a 12-month base-case target of **C$1.80** (+60.00% vs **C$1.125**) and a downside scenario of **C$0.35** (-68.89%). Forecasts are model-based projections and not guarantees.

What are the main risks when trading TMD.TO stock pre-market?

Main risks include limited liquidity, wide bid-ask spreads, extreme intraday swings, and the lack of confirmed corporate catalysts. Titan Medical's small market cap (**C$128.30M**) amplifies these trading risks.

Does Titan Medical pay dividends or have stable earnings for TMD.TO stock?

No. Titan Medical reports negative EPS (**-1.73**) and shows no dividend history. The company remains in a development phase focused on robotic surgical systems, so dividend and stable earnings are not expected near term.

CA Stocks

TSX Pre-Market: TMD.TO Titan Medical C$1.13, 117k shrs Mar 2026: liquidity watch

ByDanny Kontos March 6, 2026March 6, 2026

TMD.TO stock is trading C$1.13 in pre-market on the TSX after a sharp intraday move driven by heavy trading. Volume sits at 117,220 shares, roughly 2.55x the 30-day average, pushing market cap to about C$128.30M. The move follows an open at C$0.05 and a previous close of C$0.05, signalling extreme volatility. We examine drivers, valuation, and trading risks for Titan Medical Inc. (TSX: TMD.TO) ahead of regular hours, and provide Meyka AI’s grade and model-based forecast to frame near-term scenarios.